Relaxation and cyclic GMP levels in response to sildenafil in human pulmonary arteries from donors

European Journal of Pharmacology

Volumn 530, Issue 3, 2006, Pages 259-262

  Mauricio, Maria D ^a   Segarra, Gloria ^b   Medina, Pascual ^a   Aldasoro, Martin ^a   Martínez León, Juan B ^a   Vila, José M ^a,c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cyclic GMP; Human pulmonary artery; Nitric oxide; Sildenafil

Indexed keywords

CYCLIC GMP; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; SILDENAFIL;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PULMONARY ARTERY; SMOOTH MUSCLE RELAXATION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADULT; CYCLIC GMP; DRUG SYNERGISM; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PULMONARY ARTERY; VASODILATION; VASODILATOR AGENTS;

EID: 30444457738     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.11.042     Document Type: Article

References (16)

1. A.M. Atz, A.K. Lefler, D.L. Fairbrother, W.E. Uber, and S.M. Bradley Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises J. Thorac. Cardiovasc. Surg. 124 2002 628 629
2. M.M. Bahadur, V.D. Aggarwal, M. Mali, and A. Thamba Novel therapeutic option in hypertensive crisis: sildenafil augments nitroprusside-induced hypotension Nephrol. Dial. Transplant. 20 2005 1254 1256
3. M. Boolell, M.J. Allen, S.A. Ballard, S. Gepi-Attee, G.J. Muirhead, A.M. Naylor, I.H. Osterloh, and J.C. Gingell Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction Int. J. Impot. Res. 8 1996 47 52
4. A.T. Chuang, J.D. Strauss, R.A. Murphy, and W.D. Steers Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro J. Urol. 160 1998 257 261
5. L.J. Ignarro, H.L. Lippton, J.C. Edwards, W.H. Baricos, A.L. Hyman, P.J. Kadowitz, and C.A. Gruetter Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates J. Pharmacol. Exp. Ther. 218 1981 739 749
6. S. Lakshminrusimha, C.A. D'Angelis, J.A. Russell, L.C. Nielsen, S.F. Gugino, P.A. Nickerson, and R.H. Steinhorn C-type natriuretic peptide system in fetal ovine pulmonary vasculature Am. J. Physiol., Lung Cell. Mol. Physiol. 281 2001 L361 L368
7. H. Macarthur, M.B. Mattammal, and T.C. Westfall A new perspective on the inhibitory role of nitric oxide in sympathetic neurotransmission Biochem. Biophys. Res. Commun. 216 1995 686 692
8. P. Medina, G. Segarra, J.B. Martínez-León, J.M. Vila, M. Aldasoro, E. Otero, and S. Lluch Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels Ann. Thorac. Surg. 70 2000 1327 1331
9. P. Medina, G. Segarra, B. Torondel, P. Chuan, C. Domenech, J.M. Vila, and S. Lluch Inhibition of neuroeffector transmission in human vas deferens by sildenafil Br. J. Pharmacol 131 2000 871 874
10. P. Medina, G. Segarra, J.B. Martinez-Leon, J.M. Vila, E. Otero, and S. Lluch Relaxation and cGMP formation in response to sildenafil and sodium nitroprusside in saphenous veins from normotensive and hypertensive patients Am. J. Hypertens. 15 2002 798 802
11. L. Moreno, B. Losada, A. Cogolludo, F. Lodi, C. Lugnier, E. Villamor, M. Moro, J. Tamargo, and F. Perez-Vizcaino Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway Pediatr. Res. 56 2004 563 570
12. O. Pauvert, D. Salvail, E. Rousseau, C. Lugnier, R. Marthan, and J.P. Savineau Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery Biochem. Pharmacol. 63 2002 1763 1772
13. O. Pauvert, S. Bonnet, E. Rousseau, R. Marthan, and J.P. Savineau Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats Am. J. Physiol., Lung Cell. Mol. Physiol. 287 2004 L577 L583
14. D.J. Webb, S. Freestone, M.J. Allen, and G.J. Muirhead Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist Am. J. Cardiol. 83 1999 21C 28C
15. J. Wharton, J.W. Strange, G.M. Moller, E.J. Growcott, X. Ren, A.P. Franklyn, S.C. Phillips, and M.R. Wilkins Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells Am. J. Respir. Crit. Care Med. 172 2005 105 113
16. L. Zhao, N.A. Mason, N.W. Morrell, B. Kojonazarov, A. Sadykov, A. Maripov, M.M. Mirrakhimov, A. Aldashev, and M.R. Wilkins Sildenafil inhibits hypoxia-induced pulmonary hypertension Circulation 104 2001 424 428